Has David Provenzano, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,152,146 in general payments to David Provenzano, MD across 514 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Provenzano, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Provenzano, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Provenzano, MD

Interventional Pain Medicine · Sewickley, PANPI 1790796233

Payments from drug & device makers

$1,152,146in general payments, 2019–2025

Across 514 payments — averaging $2241.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Avanos Medical$458K
Boston Scientific$347K
Medtronic$249K
Si-bone, Inc.$58K
Nevro Corp.$21K
Abbott$16K
plus $4K from 12 others

$38,460in research payments, 2019–2025

Across 11 payments — averaging $3496.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Avanos Medical$38K

What the payments were for

Consulting fees$122,87862%
Speaking & faculty fees$56,24928%
Travel & lodging$10,2205%
Food & beverage$8,3434%
Education$1070%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Avanos Medical	102	$457,765
Boston Scientific	94	$346,915
Medtronic(2 entities)	175	$248,906
Si-bone, Inc.	68	$58,367
Nevro Corp.	29	$20,536
Abbott	24	$15,802
Brixton Biosciences, Inc.	9	$1,753
Heron Therapeutics, Inc.	1	$1,500
Vertex	1	$122
Painteq LLC	1	$102
Cerapedics Inc.	1	$99
Curonix LLC	1	$98
Saluda Medical Americas, Inc.	1	$42
Globus Medical	1	$33
Relievant Medsystems, Inc.	2	$31
Vertos Medical, Inc.	2	$30
SPR Therapeutics, Inc	1	$29
Nalu Medical, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERATOR$41,581
IFUSE IMPLANT SYSTEM$31,472
iFuse Implant$25,620
INTELLIS ADAPTIVESTIM$18,704
COOLIEF$12,081
INTELLIS$7,765
COOLIEF* COOLED RADIOFREQUENCY$6,494
GENERAL - THERAPIES$6,001
SPECTRA WAVEWRITER$4,834
RESTORE$3,570
Senza Spinal Cord Stimulation System$2,214
Inflate FX$2,040
PRECISION$1,650
HTX-011$1,500
Neural Ice$1,500
Intracept$1,114
VANTA ADAPTIVESTIM$710
ON-Q* PUMP AND ACCESSORIES$628
CLINICAL TRIAL PRODUCT$450
WaveWriter Alpha Prime 16$170

How this compares

$1,152,146 in reported general payments places this provider in the 95th percentile of 59 interventional pain medicine providers in Pennsylvania.

See all interventional pain medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$141,549

Medicare patients

364

Services billed

2,101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	456	$5,858
Buprenorphine	15	$3,966
Duloxetine Hcl	191	$3,194
Pregabalin	156	$2,231
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	132	$1,430
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	174	$1,333
Naloxone Hcl	13	$1,041
Oxycodone Hcl	52	$454
Baclofen	17	$204
Meloxicam	61	$154
Nortriptyline Hcl	13	$151
Cephalexin	28	$140
Naproxen	20	$125
Mupirocin	18	$82
Tramadol Hcl	38	$76

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Sewickley

Michael FishmanLebanon$1.5M
Fred KhaloufAltoona$490K
Keith ZoraState College$268K
Michael FarrellPittsburgh$23K
Michael FurmanYork$20K
Farshad RashidianWest Chester$19K
Chad MetzgerDarby$14K
Jorge Rivero-BecerraPittsburgh$12K
James BresnahanSpringfield$12K
Jonathan SchollIndiana$11K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →